| Search by tag or site | Login to my blog ? Start my own blog |
![]() |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Iapyx Introduces Catheter Stabilization Devices
Posted on 04/25/2007 14:29:34 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
Iapyx Medical, a San Diego firm that makes single-use medical devices, today introduced two products for reducing the risk of common hospital-acquired infections.
The Stable-Line Arterial catheter stabilization device is designed to prevent inadvertent movement and dislodgment of arterial lines. Suture securement, the traditional means of arterial line securement, increases patients’ risks of developing catheter-related bloodstream infections, which pose a significant mortality risk. Suture securement also puts healthcare workers at risk for needlestick injuries, which expose them to such diseases as Hepatitis B and C, and HIV. Iapyx’s device works without invasive sutures or conventional strips of tape. It grips the extension set to immobilize the catheter while permitting visual inspection and monitoring of the insertion site.
The Stable-Line Foley device addresses the infection risks, complications and discomfort associated with indwelling Foley (urinary) catheters. To secure Foley catheters, most clinicians use tape and leg-straps, an ineffective method that’s also inadequate against urethral irritation, meatal erosion and accidental dislodgement. Iapyx’s Stable-Line Foley minimizes these complications by securing the catheter and reducing inadvertent movement. The device, designed with a releasable and rotating dead-bolt style locking mechanism, allows for patient movement while maintaining skin integrity.
Iapyx Medical rebranded itself (from Medical Device Group) at the end of 2006. The new name is after Iapyx, a wound healer and battlefield surgeon in Greek mythology who is one of the first people credited with identifying and treating the problem of surgical site infections. Soon after the rebranding, the company secured $9 million in funding from Tavistock Life Sciences.
Source: OneMedPlace.com
________________________
Med Tech Sentinel
Iapyx Medical, a San Diego firm that makes single-use medical devices, today introduced two products for reducing the risk of common hospital-acquired infections.
The Stable-Line Arterial catheter stabilization device is designed to prevent inadvertent movement and dislodgment of arterial lines. Suture securement, the traditional means of arterial line securement, increases patients’ risks of developing catheter-related bloodstream infections, which pose a significant mortality risk. Suture securement also puts healthcare workers at risk for needlestick injuries, which expose them to such diseases as Hepatitis B and C, and HIV. Iapyx’s device works without invasive sutures or conventional strips of tape. It grips the extension set to immobilize the catheter while permitting visual inspection and monitoring of the insertion site.The Stable-Line Foley device addresses the infection risks, complications and discomfort associated with indwelling Foley (urinary) catheters. To secure Foley catheters, most clinicians use tape and leg-straps, an ineffective method that’s also inadequate against urethral irritation, meatal erosion and accidental dislodgement. Iapyx’s Stable-Line Foley minimizes these complications by securing the catheter and reducing inadvertent movement. The device, designed with a releasable and rotating dead-bolt style locking mechanism, allows for patient movement while maintaining skin integrity.
Iapyx Medical rebranded itself (from Medical Device Group) at the end of 2006. The new name is after Iapyx, a wound healer and battlefield surgeon in Greek mythology who is one of the first people credited with identifying and treating the problem of surgical site infections. Soon after the rebranding, the company secured $9 million in funding from Tavistock Life Sciences.
Source: OneMedPlace.com
________________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
![]()
- Millionaire Now! by Larry Nusbaum
- Ludwig von Mises Institute
- Credit Bloggers
- Don't Mess With Taxes
- Invest2Success
- Poor and Stupid
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Fri Jul 18, 2008 08:23AM
U.S. stock futures rebound on Citigroup results"S&a [read more]
U.S. stock futures rebound on Citigroup results"S&a [read more]












<< My Home | TheMoneyBlogs Home